Docoh
Loading...

APEN Apollo Endosurgery

News

From Benzinga Pro
Apollo Endosurgery Shares Spike Higher Following Circulation Of Doc From Australian Gov't. Dept. Of Health On Co.'s 'Endoscopic Helical Tacking System'
14 Oct 21
Biotech, News, FDA, Movers, Trading Ideas, General
https://www.ebs.tga.gov.au/servlet/xmlmillr6?dbid=ebs/PublicHTML/pdfStore.nsf&docid=4F3FF60377F1ED5ACA25876C003CB685&agid=(PrintDetailsPublic)&actionid=1
12 Health Care Stocks Moving In Thursday's Pre-Market Session
14 Oct 21
Pre-Market Outlook, Markets, Movers
20 Stocks Moving in Wednesday's Pre-Market Session
13 Oct 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Puxin Limited (NYSE: NEW) rose 52.1% to $0.6901 in pre-market trading after dipping 24% on Tuesday.
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2021
9 Sep 21
Upgrades, Downgrades, Initiation, Intraday Update, Analyst Ratings
Stephens & Co. Initiates Coverage On Apollo Endosurgery with Overweight Rating, Announces Price Target of $15
9 Sep 21
News, Price Target, Initiation, Analyst Ratings
Stephens & Co. analyst Chris Cooley initiates coverage on Apollo Endosurgery (NASDAQ:APEN) with a Overweight rating and announces Price Target of $15.
Return on Capital Employed Overview: Apollo Endosurgery
20 Aug 21
Earnings
Pulled from Benzinga Pro data Apollo Endosurgery (NASDAQ:APEN) reported Q2 sales of $16.61 million. Earnings fell to a loss of $5.24 million, resulting in a 39.61% decrease from last quarter.
Stocks That Hit 52-Week Highs On Wednesday
4 Aug 21
News, Intraday Update, Markets, Movers, Trading Ideas
Before 10 a.m. ET Wednesday, 138 stocks hit new 52-week highs.
Apollo Endosurgery Q2 EPS $(0.11) Beats $(0.20) Estimate, Sales $16.61M Beat $13.67M Estimate
3 Aug 21
Earnings, News
Apollo Endosurgery (NASDAQ:APEN) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.20) by 45 percent. This is a 63.33 percent increase over losses of $(0.30) per share from
Earnings Scheduled For August 3, 2021
3 Aug 21
Earnings, News, Pre-Market Outlook, Markets
Companies Reporting Before The Bell • Myriad Genetics (NASDAQ:MYGN) is likely to report earnings for its fourth quarter. • Stellantis (NYSE:STLA) is expected to report earnings for its second quarter.

Press releases

From Benzinga Pro
Apollo Endosurgery Announces Positive MERIT-Trial Outcomes
22 Oct 21
Biotech, News, Press Releases
Trial Results Demonstrate ESG Procedure Offers Significant and Durable Weight Loss, with Improvements in Obesity-Related Health ConditionsMERIT-Trial met its primary endpoints for safety and efficacy, with patients
Apollo Endosurgery Announces Closing of Public Offering and Exercise in Full of Option to Purchase Additional Shares
15 Oct 21
Biotech, News, Press Releases
AUSTIN, TX / ACCESSWIRE / October 15, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced today
Apollo Endosurgery Announces Pricing of $65 Million Public Offering of Common Stock
12 Oct 21
Biotech, News, Press Releases
AUSTIN, TX / ACCESSWIRE / October 12, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced today
Apollo Endosurgery Announces Commencement of Public Offering of Common Stock
12 Oct 21
Biotech, News, Press Releases
AUSTIN, TX / ACCESSWIRE / October 12, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced today
Apollo Endosurgery Announces Preliminary Third Quarter 2021 Financial Results and Provides Business Updates
7 Oct 21
Biotech, Earnings, Press Releases
Revenue expected between $16.0 million and $16.4 millionThird consecutive quarter of double-digit revenue growth; endoscopic suturing up over 30%Submitted a De Novo 510(k) Classification Request to FDA for Apollo
Apollo Endosurgery to Present at Lake Street's 5th Annual Best Ideas Growth Conference
13 Sep 21
Biotech, Events, Press Releases
AUSTIN, TX / ACCESSWIRE / September 13, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced
Apollo Endosurgery, Inc. Reports Record Endoscopy Revenue in Second Quarter, Raises Full-Year Outlook Conference Call to Discuss Results Today at 3:30 p.m. CT / 4:30 p.m. ET
3 Aug 21
Biotech, Earnings, Press Releases
AUSTIN, TX / ACCESSWIRE / August 3, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced
Apollo Endosurgery to Report Second Quarter Financial Results on August 3, 2021
27 Jul 21
Biotech, Earnings, Press Releases
AUSTIN, TX / ACCESSWIRE / July 27, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal and bariatric procedures,